Mani Sharma

Insider · Officer · AZN

Mani Sharma files insider transactions with the SEC as an officer of Astrazeneca. We hold 2 disclosed purchases and sales filed since 8 May 2026, 1 of them in the last 90 days.

Files forAZN
Disclosed buys and sells2 in all, 1 in the last 90 days
Last disclosure11 September 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed

Filed 7 April 2026 — 8 September 2026Officer · Astrazeneca 8 Form 4 lines · source: SEC Form 4

Every transaction

8 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing

Sort byOpen-market trades only8 of 8 shown


8 Sep 2026	11 Sep 2026SEC Form 4	3 d	was grantednot a trade	Astrazeneca	1 share	up +0.1%	up +0.0%
8 Aug 2026	11 Sep 2026SEC Form 4	34 d	bought on the open market	Astrazeneca	20 shares	down −0.8%	up +0.0%
6 Aug 2026	7 Aug 2026SEC Form 4	1 d	was grantednot a trade	Astrazeneca	2 shares	down −0.6%	down −0.8%
6 Jul 2026	8 Jul 2026SEC Form 4	2 d	was grantednot a trade	Astrazeneca	2 shares	down −15.8%	down −15.4%
8 Jun 2026	16 Jun 2026SEC Form 4	8 d	was grantednot a trade	Astrazeneca	1 share	down −11.8%	down −10.4%
20 May 2026	22 May 2026SEC Form 4	2 d	sold on the open market	Astrazeneca	11,893 shares	down −14.6%	down −14.4%
6 May 2026	8 May 2026SEC Form 4	2 d	was grantednot a trade	Astrazeneca	1 share	down −13.4%	down −12.4%
7 Apr 2026	8 May 2026SEC Form 4	31 d	was grantednot a trade	Astrazeneca	1 share	down −20.2%	down −12.4%

Both percentages are the stock’s move, not Mani Sharma’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 8 of the 8 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.